Clinical Trials Directory

Trials / Completed

CompletedNCT06148558

A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+

A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+ in Women With Moderate to Severe Overall Photodamage

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Revision Skincare · Industry
Sex
Female
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to evaluate the efficacy and tolerance of a moisturizer SPF 50+ when used over a 12-week time period by women with moderate to severe facial photodamage.

Detailed description

This was a single center, single-cell, 12-week clinical trial on female subjects (Fitzpatrick Skin Type I-VI, evenly distributed) between 35-60 years of age with moderate to severe overall facial photodamage. All subjects were provided Revision Skincare Gentle Foaming Cleanser and Facial Moisturizer (Goodier Cosmetics) at the Screening visit after eligibility was confirmed. These products were used twice daily as instructed for a minimum 3 days prior to the Baseline visit (washout phase). At Baseline, subjects were given Sunscreen Moisturizer SPF 50+ to replace their Facial Moisturizer morning application. Subjects continued to use the Facial Moisturizer given at Screening in the evening. Clinical grading assessments, full face images, Corneometer, Ultrasound, and subject self-assessment questionnaires were completed at each study visit (Baseline, Week 4, 8, and 12). Full face images were also completed post-application at Baseline. A total of 34 subjects completed the study.

Conditions

Interventions

TypeNameDescription
OTHERSunscreen MoisturizerA provided anti-aging sunscreen moisturizer SPF 50 was used once a day.
OTHERGentle Cleansing LotionA provided Gentle Cleansing Lotion (Revision Skincare) was used 2x daily (AM/PM).
OTHERFacial MoisturizerA provided facial moisturizer (Goodier) was used 1x daily (PM).

Timeline

Start date
2022-11-09
Primary completion
2023-02-09
Completion
2023-02-09
First posted
2023-11-28
Last updated
2023-11-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06148558. Inclusion in this directory is not an endorsement.